MedPath

Comparison of mitomycin and dexametoson in Vernal Keratoconjunctivitis

Phase 4
Completed
Conditions
vernal keratoconjunctivitis.
vernal conjunctivitis
H 10.1
Registration Number
IRCT201110097743N1
Lead Sponsor
Hamedan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
30
Inclusion Criteria

Inclusion Criteria :the paitient with Refractory Vernal Keratoconjunctivitis.
Exclusion criteria :croneal and conjunctivitis complication due to mitomycin c 0.01% efficacy of drugs.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Symptom: photophobia, tearing, itching, discharg to four grad: non complication, mild, modrat (complication half of day), sever (complication whole day). Timepoint: Befor and after treatment (after 20 days). Method of measurement: Qestion.;Conjunectival injection whit 4 grade;no injection-mild-modrat-sever bolbar injection. Timepoint: Befor and after treatment (after 20 days). Method of measurement: Examination.;Upper lid conjunectival hyperthrophy with 4grade:no-mild -modrat and sever pupillary hyperthrophia. Timepoint: Befor and after treatment (after 20 days). Method of measurement: Examination.;Puncted keratitis with 4 grade :no-Puncted in 1/4 serface of cornoal-Puncted in 1/2 serface of cornoal-Puncted in >3/4 serface of cornoal. Timepoint: Befor and after treathmen(after 20 days)t. Method of measurement: Examination.
Secondary Outcome Measures
NameTimeMethod
Trantarsal dot with 4 grade:no-(1-2)dot-(3-4)dot->4dot. Timepoint: Befor and after treathment(after 20 days). Method of measurement: Examination.;Limbal edema with 4 grade:no-<90 degree limbal area-(90-180)degree limbal area->180 degree limbal area. Timepoint: Befor and after treathment(after 20 days). Method of measurement: Examination.
© Copyright 2025. All Rights Reserved by MedPath